Unzippable Siamese Nanoparticles for Programmed Two‐Stage Cancer Immunotherapy

Author:

Long Mei1ORCID,Zhou Yanfeng1,Guo Daoxia1,Zhu Qingyun2,Liang Huan1,Ji Xiaoyuan1,Chen Nan2,Song Haiyun1ORCID

Affiliation:

1. School of Public Health Shanghai Jiao Tong University School of Medicine Shanghai 200025 China

2. College of Chemistry and Materials Science The Education Ministry Key Lab of Resource Chemistry Joint International Research Laboratory of Resource Chemistry of Ministry of Education Shanghai Key Laboratory of Rare Earth Functional Materials and Shanghai Frontiers Science Center of Biomimetic Catalysis Shanghai Normal University Shanghai 200234 China

Abstract

AbstractEpigenetic drugs (epi‐drugs) can destruct cancer cells and initiate both innate and adaptive immunity, yet they have achieved very limited success in solid tumors so far, partly attributing to their concurrent induction of the myeloid‐derived suppressor cell (MDSC) population. Here, dissociable Siamese nanoparticles (SIANPs) are developed for tumor cell‐targeted delivery of epi‐drug CM‐272 and MDSC‐targeted delivery of small molecule inhibitor Ibrutinib. The SIANPs are assembled via interparticle DNA annealing and detached via tumor microenvironment‐triggered strand separation. Such binary regulation induces endogenous retrovirus expression and immunogenic cell death in tumor cells while restraining the immunosuppressive effects of MDSCs, and synergistically promotes dendritic cell maturation and CD8+ T cell activation for tumor inhibition. Significantly, immune microenvironment remodeling via SIANPs further overcomes tumor resistance to immune checkpoint blockade therapy. This study represents a two‐pronged approach for orchestrating immune responses, and paves a new way for employing epi‐drugs in cancer immunotherapy.

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

Natural Science Foundation of Shanghai Municipality

Shanghai Municipal Health Commission

China Postdoctoral Science Foundation

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3